文献速递腹部技术与安全CTMRPET

胃神经内分泌肿瘤的风险适应性影像框架

Risk-adapted imaging of gastric neuroendocrine neoplasms: an entity-, type-, and grade-informed framework for staging and management.
PubMed 文献 · Eur J Radiol · 2026-09-23

本综述基于PubMed/MEDLINE和Web of Science检索,制定胃神经内分泌肿瘤(gastric NENs)的循证影像框架。框架区分病理实体、胃NET分型与分级,将影像选择与管理相关问题关联。提出分层双轴影像框架、模态特异性报告清单及证据不确定性表。

要点

  • Ⅰ-Ⅲ型分类仅适用于高分化胃NET,分级和不良特征作为修饰因素。
  • SSTR PET/CT与FDG PET/CT根据明确问题独立选择,不互相替代。
  • 局限期NEC考虑根治性手术者需与明确转移性NEC区分。

核心结论

  • 框架将影像选择与病理实体、胃NET分型、分级、病变范围及治疗意图对齐。
  • 该框架是循证概念框架,用于影像选择、报告和多学科决策,而非前瞻性验证的临床路径。

研究设计与样本

  • 2026年8月31日进行可重复性复检。
  • 证据在推荐/报告条目层面评价,标记为直接胃或胃十二指肠证据(G-NEN)、正式指南(GL)、更广泛胃肠胰NEN证据(GEP-NEN)或作者综合(AS)。

诊断标准与关键数值

  • Ⅰ-Ⅲ型分类仅适用于高分化胃NET,分级和不良特征作为修饰因素。
  • SSTR PET/CT与FDG PET/CT根据明确问题独立选择。
  • 局限期NEC考虑根治性手术者与明确转移性NEC进行区分。

临床应用与阅片要点

  • 影像选择需区分病理实体、胃NET分型和分级,并关联管理相关问题。
  • 使用模态特异性报告清单指导日常报告。
  • 参考证据不确定性表识别证据薄弱环节。

局限性

  • 该框架未经前瞻性验证,非临床路径。
  • 部分证据来自更广泛胃肠胰NEN研究或作者综合。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To develop an evidence-informed imaging framework for gastric neuroendocrine neoplasms (gastric NENs) that separates pathological entity, gastric NET type, and grade and links imaging selection to management-relevant questions.

METHODS: This structured narrative review used PubMed/MEDLINE and the Web of Science Core Collection through December 31, 2025, with a reproducibility rerun on August 31, 2026. Evidence was appraised at the recommendation/reporting-item level and tagged as direct gastric or gastroduodenal evidence (G-NEN), formal guidance (GL), broader gastroenteropancreatic NEN evidence (GEP-NEN), or author synthesis (AS).

RESULTS: The review yielded a hierarchical two-axis imaging framework, a modality-specific reporting checklist, and an evidence-uncertainty table. Type I-III classification is restricted to well-differentiated gastric NETs, with grade and adverse features treated as modifiers. Somatostatin receptor (SSTR) PET/CT and fluorodeoxyglucose (FDG) PET/CT are selected independently for defined questions, and localized NEC considered for curative-intent surgery is distinguished from unequivocally metastatic NEC.

CONCLUSIONS: The framework aligns imaging with pathological entity, gastric NET type, grade, disease extent, and management intent. It is an evidence-informed conceptual framework for imaging selection, reporting, and multidisciplinary decision-making rather than a prospectively validated clinical pathway.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Liu, Li, Wan, et al. Risk-adapted imaging of gastric neuroendocrine neoplasms: an entity-, type-, and grade-informed framework for staging and management. Eur J Radiol. 2026. PMID: 42800237. doi:10.1016/j.ejrad.2026.113258

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。